tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

CDNA Stock Latest News

Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
16d ago
DAL
ACHR
CareDx downgraded to Equal Weight from Overweight at Stephens
The FlyCareDx downgraded to Equal Weight from Overweight at Stephens
17d ago
CDNA
CareDx says won’t participate in Raymond James conference on scheduling conflict
The FlyCareDx says won’t participate in Raymond James conference on scheduling conflict
17d ago
CDNA
CareDx price target lowered to $19 from $25 at BTIG
The FlyCareDx price target lowered to $19 from $25 at BTIG
18d ago
CDNA
Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
The FlyStreet Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
20d ago
BILI
CDNA
CareDx downgraded to Hold at Craig-Hallum after Medicare ‘worst case scenario’
The FlyCareDx downgraded to Hold at Craig-Hallum after Medicare ‘worst case scenario’
20d ago
CDNA
CareDx downgraded to Hold from Buy at Craig-Hallum
The FlyCareDx downgraded to Hold from Buy at Craig-Hallum
21d ago
CDNA
CareDx comments on MolDX publication of new billing, coding article
The FlyCareDx comments on MolDX publication of new billing, coding article
21d ago
CDNA
CareDx double downgraded to Market Perform at Raymond James
The FlyCareDx double downgraded to Market Perform at Raymond James
21d ago
CDNA
CareDx downgraded to Market Perform from Strong Buy at Raymond James
The FlyCareDx downgraded to Market Perform from Strong Buy at Raymond James
21d ago
CDNA
Billing and coding document looks ‘clearly negative’ for CareDx, says Stephens
The FlyBilling and coding document looks ‘clearly negative’ for CareDx, says Stephens
21d ago
CDNA
CareDx price target lowered to $25 from $28 at BTIG
The FlyCareDx price target lowered to $25 from $28 at BTIG
23d ago
CDNA
CareDx price target lowered to $26 from $32 at Craig-Hallum
The FlyCareDx price target lowered to $26 from $32 at Craig-Hallum
23d ago
CDNA
CareDx reports Q4 adjusted EPS (7c), consensus (9c)
The FlyCareDx reports Q4 adjusted EPS (7c), consensus (9c)
24d ago
CDNA
CareDx to present cellular transplant progress at Tandem Meetings
The FlyCareDx to present cellular transplant progress at Tandem Meetings
1M ago
CDNA
Cathie Wood pours millions into these 2 stocks — this is what makes them attractive buys
Stock Analysis & IdeasCathie Wood pours millions into these 2 stocks — this is what makes them attractive buys
2M ago
BEAM
CDNA
CareDx sees FY23 revenue $321.3M-$321.6M, consensus $347.69M
The FlyCareDx sees FY23 revenue $321.3M-$321.6M, consensus $347.69M
2M ago
CDNA
CareDx reports preliminary Q4 revenue $81.9M-$82.2M, consensus $81.54M
The FlyCareDx reports preliminary Q4 revenue $81.9M-$82.2M, consensus $81.54M
2M ago
CDNA
CareDx says publication of ISHLT guidelines support cardiothoracic portfolio
The FlyCareDx says publication of ISHLT guidelines support cardiothoracic portfolio
3M ago
CDNA
CareDx announces $50M share repurchase plan
The FlyCareDx announces $50M share repurchase plan
4M ago
CDNA
CareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
The FlyCareDx, Natera selloffs ahead of CAC meetings overdone, says Raymond James
4M ago
CDNA
NTRA
CareDx Snaps up The Transplant Pharmacy
Market NewsCareDx Snaps up The Transplant Pharmacy
1y ago
CDNA
Insider Buying Could Indicate a Bottom in These 2 “Strong Buy” Stocks
Stock Analysis & IdeasInsider Buying Could Indicate a Bottom in These 2 “Strong Buy” Stocks
1y ago
CDNA
RVNC
CareDx Delivers Blowout Q2 Results, Raises Revenue Guidance
Market NewsCareDx Delivers Blowout Q2 Results, Raises Revenue Guidance
2y ago
CDNA
CareDx Acquires Transplant Hero, Shares Rise
Market NewsCareDx Acquires Transplant Hero, Shares Rise
2y ago
CDNA
CareDx Soars 15% As 3Q Revenue Outlook Surpasses Estimates
Market NewsCareDx Soars 15% As 3Q Revenue Outlook Surpasses Estimates
2y ago
CDNA
3 Artificial Intelligence Stocks With Long-Term Narratives
Stock Analysis & Ideas3 Artificial Intelligence Stocks With Long-Term Narratives
3y ago
CDNA
VERI
tipranks
TipRanks is a comprehensive research tool that helps investors make better, data-driven investment decisions.
Find Us on
twitterstocktwitsfacebooklinkedininstagram
Newsletter SubscriptionEnter your email to receive our newsletter
iosandroid
SitemapTerms of UsePrivacy PolicyFAQ
Research ToolsTop Smart Score StocksTrending StocksDaily Stock RatingsStock ScreenerStock ComparisonAnalysts' Top StocksDaily Insider TransactionsInsiders' Hot StocksExpert Center
CalendarsEarnings CalendarDividend CalendarIPO CalendarStock Market Holidays
EducationGlossaryTipRanks Labs
PlansPlans & PricingAPI for Institutions
CompanyAbout TipRanksContact UsReviews
Disclaimer: The TipRanks Smart Score performance is based on backtested results. Backtested performance is not an indicator of future actual results. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Changes in these assumptions may have a material impact on the backtested returns presented. Certain assumptions have been made for modeling purposes and are unlikely to be realized. No representations and warranties are made as to the reasonableness of the assumptions. This information is provided for illustrative purposes only. Backtested performance is developed with the benefit of hindsight and has inherent limitations. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Since trades have not actually been executed, results may have under- or over-compensated for the impact, if any, of certain market factors, such as lack of liquidity, and may not reflect the impact that certain economic or market factors may have had on the decision-making process. Further, backtesting allows the security selection methodology to be adjusted until past returns are maximized. Actual performance may differ significantly from backtested performance. Backtested results are adjusted to reflect the reinvestment of dividends and other income and, except where otherwise indicated, are presented gross-of fees and do not include the effect of backtested transaction costs, management fees, performance fees or expenses, if applicable. Please note all regulatory considerations regarding the presentation of fees must be taken into account. No cash balance or cash flow is included in the calculation.